In vitro DNA crosslinking by ledakrin, an antitumor derivative of 1-nitro-9-aminoacridine

Chemico-Biological Interactions

Volumn 103, Issue 2, 1997, Pages 141-151

  Bartoszek, Agnieszka ^a   Dackiewicz, Paweł ^a   Składanowski, Andrzej ^a   Konopa, Jerzy ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

1 nitroacridines; 32P post labelling assay; DNA adducts; DNA crosslinking; Ledakrin

Indexed keywords

9 AMINO 1 NITROACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; NITRACRINE; PHOSPHORUS 32;

AGAR GEL ELECTROPHORESIS; ARTICLE; DNA ADDUCT; DNA CROSS LINKING; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN;

EID: 0031588812     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(96)03754-4     Document Type: Review

References (16)

1. [1] J. Konopa, A. Ledóchowski, A. Matuszkiewicz and E. Jereczek-Morawska, In vitro studies on the cytotoxic properties of 9-aminoacridine derivatives, Neoplasma, 16 (1969) 171-179.
2. [2] M. Hrabowska, Z. Mazerska, J. Paradziej-Łukowicz, K. Onoszko and A. Ledóchowski, Antitumor activity of 1-nitro-9-aminoacridine derivatives, Drug Res., 32 (1982) 1013-1016.
3. [3] J.W. Pawlak, K. Pawlak and J. Konopa, The mode of action of cytotoxic and antitumor 1-nitroacridines II: in vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or nitracrine, with DNA and other macromolecules of mammalian or bacterial cells, Chem.-Biol. Interact., 43 (1983) 151-173.
4. [4] K. Pawlak, J.W. Pawlak and J. Konopa, Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking, Cancer Res., 44 (1984) 4289-4296.
5. 32P-Post-labelling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems, Biochem. Pharmacol., 38 (1989) 1301-1312.
6. [6] M. Gniazdowski, E. Ciesielska and L. Szmigiero, Some properties of the irreversible complexes of nitracrine (Ledakrin, C-283) with polynucleotides, Chem.-Biol. Interact., 34 (1981) 355-366.
7. [7] G.R. Fisher and L.H. Patterson, DNA strand breakage by peroxidase-activated mitoxantrone, J. Pharm. Pharmacol., 43 (1991) 65-68.
8. 32P-Post-labeling analysis of non-radioactive aromatic carcinogen-DNA adducts, Carcinogenesis, 3 (1982) 1081-1092.
9. 32P-Post-labeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents, Carcinogenesis, 5 (1984) 231-243.
10. [10] B. Wysocka-Skrzela, Research on tumor inhibiting compounds. Part LXXVI. Reactions of 1-nitro-9-aminoacridine derivatives, 16 new antitumor agents with nucleophiles, Polish J. Chem., 60 (1986) 317-318.
11. [11] A.C.M. Plooy, M. van Dijk, F. Berends and P.H.M. Lohman, Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum (II), Cancer Res., 45 (1985) 4178-4184.
12. [12] J. Hansson, R. Lewensohn, U. Ringborg and B. Nilsson, Formation and removal of DNA cross-links induced by Melphalan and Nitrogen Mustard in relation to drug-induced cytotoxicity in human melanoma cells, Cancer Res., 47 (1987) 2631-2637.
13. [13] A. Skladanowski and J. Konopa, Relevance of interstrand DNA crosslinking induced by anthracychnes for their biological activity, Biochem. Pharmacol., 47 (1994) 2279-2287.
14. [14] J. Konopa, G2 Block induced by DNA crosslinking agents and its possible consequences, Biochem. Pharmacol., 37 (1988) 2303-2309.
15. [15] J. Konopa, A. Skladanowski and R. Paulin, Induction of G2 block and apoptosis in L1210 cells by antitumor 1-nitro-9-aminoacridine (Nitracrine), Proc. Am. Assoc. Cancer Res., Orlando, Florida, 1993, Abstract No 1732.
16. [16] J.A. Hartley, M.D. Berardini and R.L. Souhami, An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and 'second arm' crosslink reactions, Anal. Biochem., 193 (1991) 131-134.